Effects of in vitro exposure of Echinococcus multilocularis metacestodes to cytostatic drugs on in vivo growth and proliferation of the parasite.
The cytostatic drugs Vincristine (VCR), Navelbine (NAV), and Methotrexate (MTX) were evaluated for their growth inhibitory potential against metacestodes of Echinococcus multilocularis (Em) by in vitro and in vivo assays. In vitro cultures of E. multilocularis were exposed to IC 90, IC 80, and IC 5 concentrations of VCR, NAV, or MTX for 1 week, then parasite tissue cultures were kept for 1 week without drug exposure in vitro, and thereafter, metacestode tissues were injected intra-peritoneally into Meriones unguiculatus. Metacestode growth was monitored for several months post-infection (p.i.) by body weight control, magnetic resonance imaging (MRI), and autopsy at 5 months p.i. Weight monitoring of infected M. unguiculatus did not provide conclusive evidence for Em-metacestode growth, while MRI could detect growing Em-metacestode in the MTX-treated group at 8 weeks (p.i.), whereas metacestodes exposed to VCR and NAV were at 17 weeks (p.i.) detectable. MRI disclosed progressive and massive growth of Em-metacestode in the VCR- and MTX-exposed groups, while the NAV-pretreated Em-metacestodes' volume did not exceed 4 cm(3). At autopsy, Em-metacestodes of less than 4 cm(3) were found in infected M. unguiculatus, which was not detected by MRI. In summary, the cytostatic drugs Methotrexate, Navelbine, and Vincristine--as applied in the present work--did not show parasitocidal or clear parasitostatic effects on metacestodes of E. multilocularis. While parasite growth in vivo was inhibited in NAV- and VCR-pretreated Em-metacestodes, MTX pretreatment seemed to enhance parasite proliferation. Magnetic resonance imaging appears suitable to monitor in vivo the effects of drugs on growth progression and regression only of larger Em-metacestode tissues.
Hübner
Cora
C
Institute for Tropical Medicine, University Clinics of Tübingen, Wilhelmstrasse. 27, 72074, Tübingen, Germany.
Wiehr
Stefan
S
Kocherscheidt
Lars
L
Wehrl
Hans
H
Pichler
Bernd J
BJ
Schmid
Andreas
A
Kern
Peter
P
Soboslay
Peter T
PT
D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology*; D001344:Autopsy; D001835:Body Weight; D054697:Cytostatic Agents / Q000494:pharmacology*; D004195:Disease Models, Animal; D004443:Echinococcosis / Q000469:parasitology / Q000473:pathology; D048210:Echinococcus multilocularis / Q000187:drug effects* / Q000254:growth & development*; D005260:Female; D005849:Gerbillinae / Q000469:parasitology; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000494:pharmacology; D014747:Vinblastine / Q000031:analogs & derivatives / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology; D000077235:Vinorelbine
D000871:Anthelmintics; D054697:Cytostatic Agents; D014750:Vincristine; D014747:Vinblastine; D000077235:Vinorelbine; D008727:Methotrexate
Expert Opin Pharmacother. 2001 Mar;2(3):409-17
11336595
Eur J Cancer. 1997 Mar;33(3):463-70
9155533
Exp Parasitol. 2008 Aug;119(4):475-82
18442817
Int J Oncol. 2008 Jun;32(6):1227-35
18497984
Parasitol Res. 2008 May;102(6):1227-34
18259776
Infection. 2001 May-Jun;29(3):119-25
11440381
Chirurg. 2000 Jan;71(1):9-15
10662996
Am J Vet Res. 2002 May;63(5):728-32
12013475
Lung Cancer. 2002 Dec;38 Suppl 4:43-9
12480194
Parasitol Res. 1995;81(7):605-14
7479653
Cancer Res. 1992 Jun 15;52(12):3396-401
1596899
J Helminthol. 2009 Jun;83(2):99-111
19296876
Gastroenterol Clin North Am. 1996 Sep;25(3):655-89
8863045
J Comput Assist Tomogr. 1990 Jul-Aug;14(4):608-14
2370360
Parasitology. 2007 Nov;134(Pt 12):1657-70
17631693
Chirurg. 2000 Jan;71(1):16-20
10662997
Clin Infect Dis. 1999 Nov;29(5):1157-63
10524957
Acta Trop. 2003 Feb;85(2):145-55
12606091
Hepatology. 1994 Mar;19(3):735-42
8119701
Oecologia. 2005 Dec;146(2):209-17
16025350
Chirurg. 2000 Jan;71(1):1-8
10662995
Nat Med. 2008 Apr;14(4):459-65
18376410
Rofo. 1990 Apr;152(4):441-5
2160106